Cargando…

Highlights from the IOB Conference on Cancer, 20-22 May 2021 and the new research vision of The Institute of Oncology Prof. Dr. Alexandru Trestioreanu, Bucharest, Romania.

The latest edition of the Bucharest Institute of Oncology (IOB) Conference was held between 20 and 22 May 2021, in the capital of Romania. The conference was a hybrid event, with live and virtual participation and was attended by more than 1000 participants. The central theme was the value added by...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurentiu, Simion, Stanculeanu, Dana, Capsa, Cristina M, Stanciu, Adina, Cristina Stefan, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426024/
https://www.ncbi.nlm.nih.gov/pubmed/34567268
http://dx.doi.org/10.3332/ecancer.2021.ed114
Descripción
Sumario:The latest edition of the Bucharest Institute of Oncology (IOB) Conference was held between 20 and 22 May 2021, in the capital of Romania. The conference was a hybrid event, with live and virtual participation and was attended by more than 1000 participants. The central theme was the value added by the tumor boards, underlining the significance of teamwork and collaboration between the different disciplines and oncology centers in the country. The opening session was attended by representatives from national and international cancer associations and societies, the mayor of Bucharest, the Vice-chancellor of the University of Medicine and Pharmacy, C. Davila, the health advisor of the President of Romania, as well other dignitaries and health experts in oncology in Romania. The conference sections covered all major types of cancer, education, research, health policies and new updates in guidelines and therapeutics. Since it is a yearly event of the institute, the current situation of the institute was presented in the context of the full COVID-19 pandemic as well as the ways of managing and overcoming the negative impact on the access to care for cancer patients.